Expert Panel Reaches Consensus on Severe Alopecia Areata Treatment

A Delphi consensus process involving 31 US-based alopecia areata experts, conducted through three rounds of iterative surveys, established agreement on treatment approaches for adults with severe alopecia areata. The panel identified oral Janus kinase inhibitors as the primary long-term therapy for all patients, with dupilumab noted as an alternative for those with comorbid atopy, alongside supplemental treatments including minoxidil, corticosteroids, and topical Janus kinase inhibitors with body-site-specific indications. The authors state these recommendations do not apply to children, pregnant patients, those with mild to moderate disease, or patients with underlying comorbidities, and note additional research is needed for these populations.

Most relevant for: Adults with severe alopecia areata, excluding children, pregnant patients, those with mild to moderate disease, or underlying comorbidities.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.